img

Global Biosimilar Monoclonal Antibody Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Biosimilar Monoclonal Antibody Market Research Report 2024

Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
Biosimilar Monoclonal Antibodies refer to the biologic medical product that are almost an identical copy of the original monoclonal antibodies but manufactured by a different company.
According to MRAResearch’s new survey, global Biosimilar Monoclonal Antibody market is projected to reach US$ 5726.4 million in 2033, increasing from US$ 4509.2 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biosimilar Monoclonal Antibody market research.
Global Biosimilar Monoclonal Antibodies key players include Celltrion, 3SBIO, Pfizer (Hospira), Novartis (Sandoz), etc. Global top four manufacturers hold a share nearly 85%.
Europe is the largest market, with a share about 40%, followed by China, and United States, both have a share about 50 percent.
In terms of product, Infliximab is the largest segment, with a share nearly 40%. And in terms of application, the largest application is Autoimmune Disease, followed by Oncology, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biosimilar Monoclonal Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Biocon
Accord Healthcare
AET Biotech
Amgen
Celltrion
Reddy's Laboratories
Hospira
3SBio
Allergan
Alvartis
Segment by Type
Limited Dilution Method
Micromanipulation
Soft Agar Plate Method
Others

Segment by Application


Chronic & Autoimmune Diseases
Oncology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biosimilar Monoclonal Antibody report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Limited Dilution Method
1.2.3 Micromanipulation
1.2.4 Soft Agar Plate Method
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biosimilar Monoclonal Antibody Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Chronic & Autoimmune Diseases
1.3.3 Oncology
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Monoclonal Antibody Market Perspective (2018-2033)
2.2 Biosimilar Monoclonal Antibody Growth Trends by Region
2.2.1 Global Biosimilar Monoclonal Antibody Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Biosimilar Monoclonal Antibody Historic Market Size by Region (2018-2023)
2.2.3 Biosimilar Monoclonal Antibody Forecasted Market Size by Region (2024-2033)
2.3 Biosimilar Monoclonal Antibody Market Dynamics
2.3.1 Biosimilar Monoclonal Antibody Industry Trends
2.3.2 Biosimilar Monoclonal Antibody Market Drivers
2.3.3 Biosimilar Monoclonal Antibody Market Challenges
2.3.4 Biosimilar Monoclonal Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Monoclonal Antibody Players by Revenue
3.1.1 Global Top Biosimilar Monoclonal Antibody Players by Revenue (2018-2023)
3.1.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Players (2018-2023)
3.2 Global Biosimilar Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosimilar Monoclonal Antibody Revenue
3.4 Global Biosimilar Monoclonal Antibody Market Concentration Ratio
3.4.1 Global Biosimilar Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibody Revenue in 2022
3.5 Biosimilar Monoclonal Antibody Key Players Head office and Area Served
3.6 Key Players Biosimilar Monoclonal Antibody Product Solution and Service
3.7 Date of Enter into Biosimilar Monoclonal Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Monoclonal Antibody Breakdown Data by Type
4.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Type (2018-2023)
4.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Type (2024-2033)
5 Biosimilar Monoclonal Antibody Breakdown Data by Application
5.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Application (2018-2023)
5.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Biosimilar Monoclonal Antibody Market Size (2018-2033)
6.2 North America Biosimilar Monoclonal Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Biosimilar Monoclonal Antibody Market Size by Country (2018-2023)
6.4 North America Biosimilar Monoclonal Antibody Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimilar Monoclonal Antibody Market Size (2018-2033)
7.2 Europe Biosimilar Monoclonal Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Biosimilar Monoclonal Antibody Market Size by Country (2018-2023)
7.4 Europe Biosimilar Monoclonal Antibody Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Monoclonal Antibody Market Size (2018-2033)
8.2 Asia-Pacific Biosimilar Monoclonal Antibody Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2018-2023)
8.4 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosimilar Monoclonal Antibody Market Size (2018-2033)
9.2 Latin America Biosimilar Monoclonal Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Biosimilar Monoclonal Antibody Market Size by Country (2018-2023)
9.4 Latin America Biosimilar Monoclonal Antibody Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Monoclonal Antibody Market Size (2018-2033)
10.2 Middle East & Africa Biosimilar Monoclonal Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2018-2023)
10.4 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocon
11.1.1 Biocon Company Detail
11.1.2 Biocon Business Overview
11.1.3 Biocon Biosimilar Monoclonal Antibody Introduction
11.1.4 Biocon Revenue in Biosimilar Monoclonal Antibody Business (2018-2023)
11.1.5 Biocon Recent Development
11.2 Accord Healthcare
11.2.1 Accord Healthcare Company Detail
11.2.2 Accord Healthcare Business Overview
11.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Introduction
11.2.4 Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2018-2023)
11.2.5 Accord Healthcare Recent Development
11.3 AET Biotech
11.3.1 AET Biotech Company Detail
11.3.2 AET Biotech Business Overview
11.3.3 AET Biotech Biosimilar Monoclonal Antibody Introduction
11.3.4 AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2018-2023)
11.3.5 AET Biotech Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Biosimilar Monoclonal Antibody Introduction
11.4.4 Amgen Revenue in Biosimilar Monoclonal Antibody Business (2018-2023)
11.4.5 Amgen Recent Development
11.5 Celltrion
11.5.1 Celltrion Company Detail
11.5.2 Celltrion Business Overview
11.5.3 Celltrion Biosimilar Monoclonal Antibody Introduction
11.5.4 Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2018-2023)
11.5.5 Celltrion Recent Development
11.6 Reddy's Laboratories
11.6.1 Reddy's Laboratories Company Detail
11.6.2 Reddy's Laboratories Business Overview
11.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Introduction
11.6.4 Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2018-2023)
11.6.5 Reddy's Laboratories Recent Development
11.7 Hospira
11.7.1 Hospira Company Detail
11.7.2 Hospira Business Overview
11.7.3 Hospira Biosimilar Monoclonal Antibody Introduction
11.7.4 Hospira Revenue in Biosimilar Monoclonal Antibody Business (2018-2023)
11.7.5 Hospira Recent Development
11.8 3SBio
11.8.1 3SBio Company Detail
11.8.2 3SBio Business Overview
11.8.3 3SBio Biosimilar Monoclonal Antibody Introduction
11.8.4 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2018-2023)
11.8.5 3SBio Recent Development
11.9 Allergan
11.9.1 Allergan Company Detail
11.9.2 Allergan Business Overview
11.9.3 Allergan Biosimilar Monoclonal Antibody Introduction
11.9.4 Allergan Revenue in Biosimilar Monoclonal Antibody Business (2018-2023)
11.9.5 Allergan Recent Development
11.10 Alvartis
11.10.1 Alvartis Company Detail
11.10.2 Alvartis Business Overview
11.10.3 Alvartis Biosimilar Monoclonal Antibody Introduction
11.10.4 Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2018-2023)
11.10.5 Alvartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Limited Dilution Method
Table 3. Key Players of Micromanipulation
Table 4. Key Players of Soft Agar Plate Method
Table 5. Key Players of Others
Table 6. Global Biosimilar Monoclonal Antibody Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Biosimilar Monoclonal Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Biosimilar Monoclonal Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Biosimilar Monoclonal Antibody Market Share by Region (2018-2023)
Table 10. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Biosimilar Monoclonal Antibody Market Share by Region (2024-2033)
Table 12. Biosimilar Monoclonal Antibody Market Trends
Table 13. Biosimilar Monoclonal Antibody Market Drivers
Table 14. Biosimilar Monoclonal Antibody Market Challenges
Table 15. Biosimilar Monoclonal Antibody Market Restraints
Table 16. Global Biosimilar Monoclonal Antibody Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Biosimilar Monoclonal Antibody Market Share by Players (2018-2023)
Table 18. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Monoclonal Antibody as of 2022)
Table 19. Ranking of Global Top Biosimilar Monoclonal Antibody Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Biosimilar Monoclonal Antibody Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Biosimilar Monoclonal Antibody Product Solution and Service
Table 23. Date of Enter into Biosimilar Monoclonal Antibody Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biosimilar Monoclonal Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2018-2023)
Table 27. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2024-2033)
Table 29. Global Biosimilar Monoclonal Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Biosimilar Monoclonal Antibody Revenue Market Share by Application (2018-2023)
Table 31. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Biosimilar Monoclonal Antibody Revenue Market Share by Application (2024-2033)
Table 33. North America Biosimilar Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Biosimilar Monoclonal Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Biosimilar Monoclonal Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Biosimilar Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Biosimilar Monoclonal Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Biosimilar Monoclonal Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Biosimilar Monoclonal Antibody Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Biosimilar Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Biosimilar Monoclonal Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Biosimilar Monoclonal Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 48. Biocon Company Detail
Table 49. Biocon Business Overview
Table 50. Biocon Biosimilar Monoclonal Antibody Product
Table 51. Biocon Revenue in Biosimilar Monoclonal Antibody Business (2018-2023) & (US$ Million)
Table 52. Biocon Recent Development
Table 53. Accord Healthcare Company Detail
Table 54. Accord Healthcare Business Overview
Table 55. Accord Healthcare Biosimilar Monoclonal Antibody Product
Table 56. Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2018-2023) & (US$ Million)
Table 57. Accord Healthcare Recent Development
Table 58. AET Biotech Company Detail
Table 59. AET Biotech Business Overview
Table 60. AET Biotech Biosimilar Monoclonal Antibody Product
Table 61. AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2018-2023) & (US$ Million)
Table 62. AET Biotech Recent Development
Table 63. Amgen Company Detail
Table 64. Amgen Business Overview
Table 65. Amgen Biosimilar Monoclonal Antibody Product
Table 66. Amgen Revenue in Biosimilar Monoclonal Antibody Business (2018-2023) & (US$ Million)
Table 67. Amgen Recent Development
Table 68. Celltrion Company Detail
Table 69. Celltrion Business Overview
Table 70. Celltrion Biosimilar Monoclonal Antibody Product
Table 71. Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2018-2023) & (US$ Million)
Table 72. Celltrion Recent Development
Table 73. Reddy's Laboratories Company Detail
Table 74. Reddy's Laboratories Business Overview
Table 75. Reddy's Laboratories Biosimilar Monoclonal Antibody Product
Table 76. Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2018-2023) & (US$ Million)
Table 77. Reddy's Laboratories Recent Development
Table 78. Hospira Company Detail
Table 79. Hospira Business Overview
Table 80. Hospira Biosimilar Monoclonal Antibody Product
Table 81. Hospira Revenue in Biosimilar Monoclonal Antibody Business (2018-2023) & (US$ Million)
Table 82. Hospira Recent Development
Table 83. 3SBio Company Detail
Table 84. 3SBio Business Overview
Table 85. 3SBio Biosimilar Monoclonal Antibody Product
Table 86. 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2018-2023) & (US$ Million)
Table 87. 3SBio Recent Development
Table 88. Allergan Company Detail
Table 89. Allergan Business Overview
Table 90. Allergan Biosimilar Monoclonal Antibody Product
Table 91. Allergan Revenue in Biosimilar Monoclonal Antibody Business (2018-2023) & (US$ Million)
Table 92. Allergan Recent Development
Table 93. Alvartis Company Detail
Table 94. Alvartis Business Overview
Table 95. Alvartis Biosimilar Monoclonal Antibody Product
Table 96. Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2018-2023) & (US$ Million)
Table 97. Alvartis Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar Monoclonal Antibody Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Biosimilar Monoclonal Antibody Market Share by Type: 2022 VS 2033
Figure 3. Limited Dilution Method Features
Figure 4. Micromanipulation Features
Figure 5. Soft Agar Plate Method Features
Figure 6. Others Features
Figure 7. Global Biosimilar Monoclonal Antibody Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Biosimilar Monoclonal Antibody Market Share by Application: 2022 VS 2033
Figure 9. Chronic & Autoimmune Diseases Case Studies
Figure 10. Oncology Case Studies
Figure 11. Others Case Studies
Figure 12. Biosimilar Monoclonal Antibody Report Years Considered
Figure 13. Global Biosimilar Monoclonal Antibody Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Biosimilar Monoclonal Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Biosimilar Monoclonal Antibody Market Share by Region: 2022 VS 2033
Figure 16. Global Biosimilar Monoclonal Antibody Market Share by Players in 2022
Figure 17. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Monoclonal Antibody as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Biosimilar Monoclonal Antibody Revenue in 2022
Figure 19. North America Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Biosimilar Monoclonal Antibody Market Share by Country (2018-2033)
Figure 21. United States Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Biosimilar Monoclonal Antibody Market Share by Country (2018-2033)
Figure 25. Germany Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Biosimilar Monoclonal Antibody Market Share by Region (2018-2033)
Figure 33. China Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Biosimilar Monoclonal Antibody Market Share by Country (2018-2033)
Figure 41. Mexico Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Biosimilar Monoclonal Antibody Market Share by Country (2018-2033)
Figure 45. Turkey Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Biosimilar Monoclonal Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Biocon Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2018-2023)
Figure 48. Accord Healthcare Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2018-2023)
Figure 49. AET Biotech Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2018-2023)
Figure 50. Amgen Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2018-2023)
Figure 51. Celltrion Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2018-2023)
Figure 52. Reddy's Laboratories Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2018-2023)
Figure 53. Hospira Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2018-2023)
Figure 54. 3SBio Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2018-2023)
Figure 55. Allergan Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2018-2023)
Figure 56. Alvartis Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries